期(qi)刊中文名:自(zi)身免疫性疾病ISSN:2090-0422E-ISSN:2090-0430
該雜(za)志(zhi)國際(ji)簡稱(cheng):AUTOIMMUN DIS,是由出版商Hindawi Limited出版的(de)一本致(zhi)力于發(fa)(fa)布--研(yan)究(jiu)新成果(guo)的(de)的(de)專(zhuan)業(ye)學(xue)術期刊(kan)。主要發(fa)(fa)表刊(kan)登有創見的(de)學(xue)術論文(wen)文(wen)章、行業(ye)最(zui)新科(ke)研(yan)成果(guo),扼要報道(dao)階(jie)段性研(yan)究(jiu)成果(guo)和重要研(yan)究(jiu)工作(zuo)的(de)最(zui)新進(jin)展,選載對學(xue)科(ke)發(fa)(fa)展起指導作(zuo)用(yong)的(de)綜(zong)述與(yu)專(zhuan)論,促(cu)進(jin)學(xue)術發(fa)(fa)展,為廣大(da)讀者服務。該刊(kan)是一本國際(ji)優秀雜(za)志(zhi),在國際(ji)上(shang)有很高的(de)學(xue)術影響力。
《Autoimmune Diseases》是一本(ben)以(yi)(yi)English為主的(de)(de)開放獲(huo)取國(guo)際(ji)優(you)秀(xiu)期(qi)刊(kan)(kan),中文名稱自身(shen)免疫(yi)性疾(ji)病,本(ben)刊(kan)(kan)主要出(chu)版、報(bao)道領域(yu)(yu)的(de)(de)研究動(dong)態以(yi)(yi)及在該(gai)領域(yu)(yu)取得的(de)(de)各方(fang)面的(de)(de)經(jing)驗和(he)科(ke)研成(cheng)果,介紹該(gai)領域(yu)(yu)有(you)關本(ben)專業(ye)(ye)的(de)(de)最(zui)新(xin)(xin)進展(zhan),探討(tao)行(xing)業(ye)(ye)發(fa)展(zhan)的(de)(de)思路(lu)和(he)方(fang)法,以(yi)(yi)促進學(xue)術信息交流,提高行(xing)業(ye)(ye)發(fa)展(zhan)。該(gai)刊(kan)(kan)已被國(guo)際(ji)權威數據(ju)庫SCIE收錄,為該(gai)領域(yu)(yu)相關學(xue)科(ke)的(de)(de)發(fa)展(zhan)起到了良好的(de)(de)推(tui)動(dong)作用(yong),也得到了本(ben)專業(ye)(ye)人員(yuan)的(de)(de)廣泛認可。該(gai)刊(kan)(kan)最(zui)新(xin)(xin)影響(xiang)因子(zi)為1.7,最(zui)新(xin)(xin)CiteScore 指數為6.1。
Autoimmune Diseases is an internationally peer-reviewed journal dedicated to the study of autoimmune diseases. This magazine covers various aspects of autoimmune diseases, including pathophysiology, diagnosis, treatment, and prevention strategies. It aims to provide a platform for researchers, clinical doctors, and other health professionals to exchange the latest research findings and clinical experiences.
The magazine has a wide range of content, including original research articles, reviews, case reports, and thematic discussions. These articles not only explore the basic mechanisms of autoimmune diseases, but also focus on the development of new treatment methods and the improvement of existing treatment methods. The magazine places special emphasis on translational research, which refers to studies that can translate laboratory research results into clinical applications. The review process of this journal is strict, ensuring that published articles have high scientific standards and clinical relevance. In this way, it has made important contributions to promoting scientific progress in the field of autoimmune diseases and improving the quality of patient care.
按(an)JIF指標學科分區 |
學科:IMMUNOLOGY
收錄子集:ESCI
分區:Q4
排名:150 / 181
百分位:
17.4% |
按JCI指標學科分(fen)區 |
學科:IMMUNOLOGY
收錄子集:ESCI
分區:Q4
排名:157 / 181
百分位:
13.54% |
JCR分區:JCR分(fen)區(qu)來自科(ke)睿唯(wei)安公司,JCR是一(yi)個獨特(te)的(de)(de)多學(xue)(xue)科(ke)期(qi)刊(kan)評(ping)(ping)價工具,為唯(wei)一(yi)提供基于引文數據(ju)的(de)(de)統計信(xin)息的(de)(de)期(qi)刊(kan)評(ping)(ping)價資源。每(mei)年(nian)發布的(de)(de)JCR分(fen)區(qu),設(she)置了254個具體學(xue)(xue)科(ke)。JCR分(fen)區(qu)根據(ju)每(mei)個學(xue)(xue)科(ke)分(fen)類按照(zhao)期(qi)刊(kan)當(dang)年(nian)的(de)(de)影響因子高(gao)低將期(qi)刊(kan)平均分(fen)為4個區(qu),分(fen)別為Q1、Q2、Q3和Q4,各占(zhan)25%。JCR分(fen)區(qu)中(zhong)期(qi)刊(kan)的(de)(de)數量是均勻分(fen)為四個部分(fen)的(de)(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Immunology and Microbiology 小類:Immunology and Microbiology (miscellaneous) | Q1 | 7 / 29 |
77% |
大類:Immunology and Microbiology 小類:Immunology and Allergy | Q2 | 97 / 233 |
58% |
大類:Immunology and Microbiology 小類:Immunology | Q2 | 116 / 236 |
51% |
該(gai)(gai)雜(za)志是(shi)一本國(guo)際(ji)(ji)優(you)秀雜(za)志,在國(guo)際(ji)(ji)上有較高(gao)的學(xue)術影響力,行(xing)業(ye)關注度很(hen)高(gao),已被(bei)國(guo)際(ji)(ji)權威數據庫(ku)SCIE收錄(lu),該(gai)(gai)雜(za)志在綜合(he)專(zhuan)業(ye)領域專(zhuan)業(ye)度認可很(hen)高(gao),對稿(gao)(gao)(gao)件內容的創新性(xing)和學(xue)術性(xing)要(yao)求很(hen)高(gao),作為(wei)一本國(guo)際(ji)(ji)優(you)秀雜(za)志,一般投(tou)稿(gao)(gao)(gao)過(guo)(guo)審時間都較長,投(tou)稿(gao)(gao)(gao)過(guo)(guo)審時間平均(jun) 17 Weeks ,如(ru)(ru)果想(xiang)(xiang)投(tou)稿(gao)(gao)(gao)該(gai)(gai)刊要(yao)做好時間安排。版面(mian)費不祥。該(gai)(gai)雜(za)志近兩年未(wei)被(bei)列入預警名單,建(jian)議您(nin)投(tou)稿(gao)(gao)(gao)。如(ru)(ru)您(nin)想(xiang)(xiang)了(le)解(jie)更多投(tou)稿(gao)(gao)(gao)政策(ce)及投(tou)稿(gao)(gao)(gao)方案,請咨詢(xun)客服。
若用戶需(xu)要出版服(fu)務,請聯系出版商。